154 related articles for article (PubMed ID: 8605274)
1. C-kit receptor (CD117) expression in acute leukemia.
Valverde LR; Matutes E; Farahat N; Heffernan A; Owusu-Ankomah K; Morilla R; Catovsky D
Ann Hematol; 1996 Jan; 72(1):11-5. PubMed ID: 8605274
[TBL] [Abstract][Full Text] [Related]
2. Enhanced myeloid specificity of CD117 compared with CD13 and CD33.
Nomdedéu JF; Mateu R; Altès A; Llorente A; Rio C; Estivill C; López O; Ubeda J; Rubiol E
Leuk Res; 1999 Apr; 23(4):341-7. PubMed ID: 10229319
[TBL] [Abstract][Full Text] [Related]
3. CD117/CD34 expression in leukemic blasts.
Wells SJ; Bray RA; Stempora LL; Farhi DC
Am J Clin Pathol; 1996 Aug; 106(2):192-5. PubMed ID: 8712172
[TBL] [Abstract][Full Text] [Related]
4. CD117 (c-kit) is a restricted antigen of acute myeloid leukemia and characterizes early differentiative levels of M5 FAB subtype.
Cascavilla N; Musto P; D'Arena G; Melillo L; Carella AM; Petrilli MP; Sanpaolo G; Carotenuto M
Haematologica; 1998 May; 83(5):392-7. PubMed ID: 9658721
[TBL] [Abstract][Full Text] [Related]
5. The reliability and specificity of c-kit for the diagnosis of acute myeloid leukemias and undifferentiated leukemias. The European Group for the Immunological Classification of Leukemias (EGIL).
Bene MC; Bernier M; Casasnovas RO; Castoldi G; Knapp W; Lanza F; Ludwig WD; Matutes E; Orfao A; Sperling C; van't Veer MB
Blood; 1998 Jul; 92(2):596-9. PubMed ID: 9657760
[TBL] [Abstract][Full Text] [Related]
6. C-kit receptor tyrosine kinase (CD117) expression and its positive predictive value for the diagnosis of Thai adult acute myeloid leukemia.
Auewarakul CU; Lauhakirti D; Promsuwicha O; Munkhetvit C
Ann Hematol; 2006 Feb; 85(2):108-12. PubMed ID: 16320053
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of anti-CD117 in the flow cytometric analysis of acute leukemia.
Hans CP; Finn WG; Singleton TP; Schnitzer B; Ross CW
Am J Clin Pathol; 2002 Feb; 117(2):301-5. PubMed ID: 11863227
[TBL] [Abstract][Full Text] [Related]
8. Expression of the YB5.B8 antigen (c-kit proto-oncogene product) in normal human bone marrow.
Ashman LK; Cambareri AC; To LB; Levinsky RJ; Juttner CA
Blood; 1991 Jul; 78(1):30-7. PubMed ID: 1712644
[TBL] [Abstract][Full Text] [Related]
9. The c-kit molecule and the surface immunophenotype of human acute leukemia.
Kubota A; Okamura S; Shimoda K; Harada M; Niho Y
Leuk Lymphoma; 1994 Aug; 14(5-6):421-8. PubMed ID: 7529077
[TBL] [Abstract][Full Text] [Related]
10. Expression of the stem cell factor receptor C-KIT (CD117) in acute leukemias.
Sperling C; Schwartz S; Büchner T; Thiel E; Ludwig WD
Haematologica; 1997; 82(5):617-21. PubMed ID: 9407735
[TBL] [Abstract][Full Text] [Related]
11. AML: immunophenotypic heterogeneity and prognostic significance of c-kit expression.
Reuss-Borst MA; Bühring HJ; Schmidt H; Müller CA
Leukemia; 1994 Feb; 8(2):258-63. PubMed ID: 7508533
[TBL] [Abstract][Full Text] [Related]
12. Expression of c-Kit and functional drug efflux are correlated in de novo acute myeloid leukaemia.
Sincock PM; Ashman LK
Leukemia; 1997 Nov; 11(11):1850-7. PubMed ID: 9369417
[TBL] [Abstract][Full Text] [Related]
13. Cytofluorimetric and functional analysis of c-kit receptor in acute leukemia.
Lauria F; Bagnara GP; Rondelli D; Raspadori D; Strippoli P; Bonsi L; Ventura MA; Montanaro LL; Bubola G; Tura S
Leuk Lymphoma; 1995 Aug; 18(5-6):451-5. PubMed ID: 8528052
[TBL] [Abstract][Full Text] [Related]
14. [Analysis of CD117 expression on leukemia cells].
Shen HQ; Tang YM; Yang SL; Qian BQ; Song H; Shi SW; Xu WQ
Zhonghua Xue Ye Xue Za Zhi; 2003 May; 24(5):228-30. PubMed ID: 12859870
[TBL] [Abstract][Full Text] [Related]
15. Expression of c-kit receptor (CD117) and CD34 in leukemic cells.
Muroi K; Nakamura M; Amemiya Y; Suda T; Miura Y
Leuk Lymphoma; 1995 Jan; 16(3-4):297-305. PubMed ID: 7536510
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibody YB5.B8 identifies the human c-kit protein product.
Lerner NB; Nocka KH; Cole SR; Qiu FH; Strife A; Ashman LK; Besmer P
Blood; 1991 May; 77(9):1876-83. PubMed ID: 1708291
[TBL] [Abstract][Full Text] [Related]
17. Expression of the C-kit receptor (CD117) is a feature of almost all subtypes of de novo acute myeloblastic leukemia (AML), including cytogenetically good-risk AML, and lacks prognostic significance.
Schwartz S; Heinecke A; Zimmermann M; Creutzig U; Schoch C; Harbott J; Fonatsch C; Löffler H; Büchner T; Ludwig WD; Thiel E
Leuk Lymphoma; 1999 Jun; 34(1-2):85-94. PubMed ID: 10350335
[TBL] [Abstract][Full Text] [Related]
18. c-Kit (CD117) reactivity in extramedullary myeloid tumor/granulocytic sarcoma.
Chen J; Yanuck RR; Abbondanzo SL; Chu WS; Aguilera NS
Arch Pathol Lab Med; 2001 Nov; 125(11):1448-52. PubMed ID: 11698000
[TBL] [Abstract][Full Text] [Related]
19. CD34/CD117 co-expression in childhood acute leukemia.
Uçkan D; Hiçsönmez G; Yetgin S; Gürgey A; Cetin M; Karaağaoğlu E; Okur H; Tuncer AM
Leuk Res; 2000 Mar; 24(3):201-6. PubMed ID: 10739002
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of CD117 in differential diagnosis of acute leukemias.
Ahmadi A; Poorfathollah AA; Aghaiipour M; Rezaei M; Nikoo-ghoftar M; Abdi M; Gharib A; Amini A
Tumour Biol; 2014 Jul; 35(7):6763-8. PubMed ID: 24722823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
